160 related articles for article (PubMed ID: 33080736)
1. MR prediction of pathologic complete response and early-stage rectal cancer after neoadjuvant chemoradiation in patients with clinical T1/T2 rectal cancer for organ saving strategy.
Bae H; Seo N; Han K; Koom WS; Kim MJ; Kim NK; Lim JS
Medicine (Baltimore); 2020 Oct; 99(42):e22746. PubMed ID: 33080736
[TBL] [Abstract][Full Text] [Related]
2. Preoperative concurrent chemoradiotherapy MRI characteristics favouring pathologic complete response in patients with rectal cancer: Usefulness of MR T2-stage as an ancillary finding for predicting pathologic complete response.
Lee HJ; Chung WS; An JH; Kim JH
J Med Imaging Radiat Oncol; 2021 Apr; 65(2):166-174. PubMed ID: 33319450
[TBL] [Abstract][Full Text] [Related]
3. MRI Risk Stratification for Tumor Relapse in Rectal Cancer Achieving Pathological Complete Remission after Neoadjuvant Chemoradiation Therapy and Curative Resection.
Kim H; Myoung S; Koom WS; Kim NK; Kim MJ; Ahn JB; Hur H; Lim JS
PLoS One; 2016; 11(1):e0146235. PubMed ID: 26730717
[TBL] [Abstract][Full Text] [Related]
4. MRI Assessment of Complete Response to Preoperative Chemoradiation Therapy for Rectal Cancer: 2020 Guide for Practice from the Korean Society of Abdominal Radiology.
Park SH; Cho SH; Choi SH; Jang JK; Kim MJ; Kim SH; Lim JS; Moon SK; Park JH; Seo N;
Korean J Radiol; 2020 Jul; 21(7):812-828. PubMed ID: 32524782
[TBL] [Abstract][Full Text] [Related]
5. T2-weighted signal intensity-selected volumetry for prediction of pathological complete response after preoperative chemoradiotherapy in locally advanced rectal cancer.
Kim S; Han K; Seo N; Kim HJ; Kim MJ; Koom WS; Ahn JB; Lim JS
Eur Radiol; 2018 Dec; 28(12):5231-5240. PubMed ID: 29858637
[TBL] [Abstract][Full Text] [Related]
6. Quantitative synthetic MRI for predicting locally advanced rectal cancer response to neoadjuvant chemoradiotherapy.
Lian S; Liu H; Meng T; Ma L; Zeng W; Xie C
Eur Radiol; 2023 Mar; 33(3):1737-1745. PubMed ID: 36380196
[TBL] [Abstract][Full Text] [Related]
7. [Application value of texture analysis of magnetic resonance images in prediction of neoadjuvant chemoradiotherapy efficacy for rectal cancer].
Shu Z; Fang S; Ding Z; Mao D; Pang P; Gong X
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Sep; 21(9):1051-1058. PubMed ID: 30269327
[TBL] [Abstract][Full Text] [Related]
8. Endoscopy and magnetic resonance imaging-based prediction of ypT stage in patients with rectal cancer who received chemoradiotherapy: Results from a prospective study of 110 patients.
Cho MS; Kim H; Han YD; Hur H; Min BS; Baik SH; Cheon JH; Lim JS; Lee KY; Kim NK
Medicine (Baltimore); 2019 Aug; 98(35):e16614. PubMed ID: 31464897
[TBL] [Abstract][Full Text] [Related]
9. How to Combine Diffusion-Weighted and T2-Weighted Imaging for MRI Assessment of Pathologic Complete Response to Neoadjuvant Chemoradiotherapy in Patients with Rectal Cancer?
Jang JK; Lee CM; Park SH; Kim JH; Kim J; Lim SB; Yu CS; Kim JC
Korean J Radiol; 2021 Sep; 22(9):1451-1461. PubMed ID: 34132075
[TBL] [Abstract][Full Text] [Related]
10. Diffusion-weighted MRI and MR- volumetry--in the evaluation of tumor response after preoperative chemoradiotherapy in patients with locally advanced rectal cancer.
Birlik B; Obuz F; Elibol FD; Celik AO; Sokmen S; Terzi C; Sagol O; Sarioglu S; Gorken I; Oztop I
Magn Reson Imaging; 2015 Feb; 33(2):201-12. PubMed ID: 25460330
[TBL] [Abstract][Full Text] [Related]
11. Prediction of pathologic staging with magnetic resonance imaging after preoperative chemoradiotherapy in rectal cancer: pooled analysis of KROG 10-01 and 11-02.
Lee JH; Jang HS; Kim JG; Lee MA; Kim DY; Kim TH; Oh JH; Park SC; Kim SY; Baek JY; Park HC; Kim HC; Nam TK; Chie EK; Jung JH; Oh ST
Radiother Oncol; 2014 Oct; 113(1):18-23. PubMed ID: 25245559
[TBL] [Abstract][Full Text] [Related]
12. Response assessment after (chemo)radiotherapy for rectal cancer: Why are we missing complete responses with MRI and endoscopy?
van der Sande ME; Beets GL; Hupkens BJ; Breukink SO; Melenhorst J; Bakers FC; Lambregts DM; Grabsch HI; Beets-Tan RG; Maas M
Eur J Surg Oncol; 2019 Jun; 45(6):1011-1017. PubMed ID: 30528891
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic performance of magnetic resonance to assess treatment response after neoadjuvant therapy in patients with locally advanced rectal cancer.
Nahas SC; Nahas CSR; Cama GM; de Azambuja RL; Horvat N; Marques CFS; Menezes MR; Junior UR; Cecconello I
Abdom Radiol (NY); 2019 Nov; 44(11):3632-3640. PubMed ID: 30663025
[TBL] [Abstract][Full Text] [Related]
14. Machine learning for prediction of chemoradiation therapy response in rectal cancer using pre-treatment and mid-radiation multi-parametric MRI.
Shi L; Zhang Y; Nie K; Sun X; Niu T; Yue N; Kwong T; Chang P; Chow D; Chen JH; Su MY
Magn Reson Imaging; 2019 Sep; 61():33-40. PubMed ID: 31059768
[TBL] [Abstract][Full Text] [Related]
15. Impact of PET/CT for Restaging Patients With Locally Advanced Rectal Cancer After Neoadjuvant Chemoradiation.
Sorenson E; Lambreton F; Yu JQ; Li T; Denlinger CS; Meyer JE; Sigurdson ER; Farma JM
J Surg Res; 2019 Nov; 243():242-248. PubMed ID: 31229791
[TBL] [Abstract][Full Text] [Related]
16. Comparison of pathological complete response rates after neoadjuvant short-course radiotherapy or chemoradiation followed by delayed surgery in locally advanced rectal cancer.
Hoendervangers S; Couwenberg AM; Intven MPW; van Grevenstein WMU; Verkooijen HM
Eur J Surg Oncol; 2018 Jul; 44(7):1013-1017. PubMed ID: 29650419
[TBL] [Abstract][Full Text] [Related]
17. Diffusion-weighted imaging: Apparent diffusion coefficient histogram analysis for detecting pathologic complete response to chemoradiotherapy in locally advanced rectal cancer.
Choi MH; Oh SN; Rha SE; Choi JI; Lee SH; Jang HS; Kim JG; Grimm R; Son Y
J Magn Reson Imaging; 2016 Jul; 44(1):212-20. PubMed ID: 26666560
[TBL] [Abstract][Full Text] [Related]
18. [Application of magnetic resonance in "non-operative treatment" strategy for rectal cancer].
Wang Y; Chen G
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Jun; 20(6):630-634. PubMed ID: 28643307
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of diffusion kurtosis and diffusivity from baseline staging MRI as predictive biomarkers for response to neoadjuvant chemoradiation in locally advanced rectal cancer.
Bates DDB; Mazaheri Y; Lobaugh S; Golia Pernicka JS; Paroder V; Shia J; Zheng J; Capanu M; Petkovska I; Gollub MJ
Abdom Radiol (NY); 2019 Nov; 44(11):3701-3708. PubMed ID: 31154482
[TBL] [Abstract][Full Text] [Related]
20. Predictive Factors for Pathologic Complete Response Following Neoadjuvant Chemoradiotherapy for Rectal Cancer.
Zhang Q; Liang J; Chen J; Mei S; Wang Z
Asian Pac J Cancer Prev; 2021 May; 22(5):1607-1611. PubMed ID: 34048192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
